Assessing the robustness of direct meta-analysis in the presence of heterogeneity.
To assess robustness of findings in recent systematic reviews of atypical antipsychotics in schizophrenia patients in the presence of heterogeneity. Relative efficacy was measured in seven direct comparisons of mean difference (MD) in average positive and negative syndrome scale total score and comparisons between conventional meta-analysis results and four alternate meta-analytic strategies using the difference in MD (ΔMD). MDs in positive and negative syndrome scale total score were smaller in the conventional meta-analyses than those for three of the four analytic strategies. Such differences were small (all ΔMD <4). No considerable differences in effect size were observed in the limit meta-analysis comparison (|ΔMD| <1). The analyses validated the systematic review results and demonstrate the value of confirmatory sensitivity analysis.